4536.T
4536.T
JP3336000009
SANTEN PHARMACEUTICAL CO
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2026 2025 Change %
Total Revenue 291.624.000.000 300.004.000.000
2.8%
Cost of Revenue 121.881.000.000 128.977.000.000
5.5%
Gross Profit 169.743.000.000 171.027.000.000
0.8%
121.945.000.000 124.147.000.000
1.8%
Operating Income 47.798.000.000 46.880.000.000
2.0%
Pretax Income 47.442.000.000 47.481.000.000
0.1%
Net Income Common Stockholders 37.361.000.000 36.247.000.000
3.1%
-- --
--
-- --
--
ende